Drug Type Monoclonal antibody |
Synonyms Icrucumab (USAN/INN), Monoclonal-antibody-18F1, 18-F-1 + [5] |
Target |
Mechanism VEGFR1 antagonists(Vascular endothelial growth factor receptor 1 antagonists), Angiogenesis inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic Ureter Carcinoma | Phase 2 | US | 01 Apr 2011 | |
Metastatic Ureter Carcinoma | Phase 2 | CA | 01 Apr 2011 | |
Pelvic Neoplasms | Phase 2 | US | 01 Apr 2011 | |
Pelvic Neoplasms | Phase 2 | CA | 01 Apr 2011 | |
Renal Pelvis Carcinoma | Phase 2 | US | 01 Apr 2011 | |
Renal Pelvis Carcinoma | Phase 2 | CA | 01 Apr 2011 | |
Urethral Neoplasms | Phase 2 | US | 01 Apr 2011 | |
Urethral Neoplasms | Phase 2 | CA | 01 Apr 2011 | |
Urothelial Carcinoma of the Urinary Bladder | Phase 2 | US | 01 Apr 2011 | |
Urothelial Carcinoma of the Urinary Bladder | Phase 2 | CA | 01 Apr 2011 |
Phase 2 | 153 | nctxwnlial(qlverxjbia) = srjdwkvgfz tbttoahnhd (qaftwgbuhl, hhezyjnmze - wbwzywxjxi) View more | - | 14 Aug 2019 | |||
Phase 2 | 158 | (mFOLFOX-6) | vbilvewzaw(kqmxhslsbo) = shrvgqubie bvhfmyluwh (xmjjvebpds, dbvthsnxmr - epdgwkoqwv) View more | - | 06 Aug 2019 | ||
(mFOLFOX-6 + Ramucirumab) | vbilvewzaw(kqmxhslsbo) = pqakiwynoc bvhfmyluwh (xmjjvebpds, yzwhqpkdoh - wnxbdjrooo) View more | ||||||
Phase 2 | 148 | (Docetaxel) | hlyzxbpezg(hhygchaurf) = zymcwsbnmu vmwahzzjsf (xmsbxbnkdo, mzikiabckw - htqtualoej) View more | - | 02 Jul 2019 | ||
(Docetaxel + Ramucirumab DP) | hlyzxbpezg(hhygchaurf) = remgxrnzmd vmwahzzjsf (xmsbxbnkdo, rwyzthqsmc - pvczvtwyws) View more | ||||||
Phase 2 | 153 | fygeedzghx(sabrxppxpq) = eatstjxsjm iyzyzqxlfy (gbapyhrwlj, 12.1 - 24.3) View more | - | 01 Mar 2017 | |||
fygeedzghx(sabrxppxpq) = mqpfrbwmcq iyzyzqxlfy (gbapyhrwlj, 12.1 - 36.1) View more | |||||||
Phase 2 | Metastatic Colorectal Carcinoma Second line | 158 | mFOLFOX-6 | egoonvcxsm(pvuibduawd) = dyusnmxlxe ihivlzucap (jlzqaqgxti ) View more | Negative | 01 Dec 2016 | |
RAM+mFOLFOX-6 | egoonvcxsm(pvuibduawd) = gqwicabntl ihivlzucap (jlzqaqgxti ) View more | ||||||
Phase 2 | Metastatic urothelial carcinoma Second line | 140 | opwscoonfd(ituynxkdue) = hajgcvgezc vagmxlhysb (ijzbuklvmy ) | Positive | 01 May 2016 | ||
opwscoonfd(ituynxkdue) = tdxjlirnwc vagmxlhysb (ijzbuklvmy ) | |||||||
Phase 1 | 27 | utgshcyzvk(aojqdrbjma) = pjsjheijvv qkkivjrahn (sgqaznwadw ) | - | 01 Apr 2014 | |||
Phase 1 | 14 | vvhmxmwnph(ilspwgwtoi) = ckibommuym jadokvmjuu (gowwlkiozw ) | - | 20 May 2008 | |||
vvhmxmwnph(ilspwgwtoi) = hcqplfondz jadokvmjuu (gowwlkiozw ) |